Patents by Inventor Lawrence Maranucci

Lawrence Maranucci has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF USING SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONS
    Publication number: 20120164078
    Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at about 12 hours and the use of the composition to treat various neurological diseases, including multiple sclerosis. A method of selecting individuals based on responsiveness to a treatment, including, for example, identifying individuals who responded to treatment with a sustained release fampridine composition.
    Type: Application
    Filed: March 2, 2012
    Publication date: June 28, 2012
    Inventors: Andrew R. Blight, Lawrence Maranucci, Ron Cohen
  • METHODS OF USING SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONS
    Publication number: 20120064007
    Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at about 12 hours and the use of the composition to treat various neurological diseases, including multiple sclerosis. A method of selecting individuals based on responsiveness to a treatment, including, for example, identifying individuals who responded to treatment with a sustained release fampridine composition.
    Type: Application
    Filed: November 18, 2011
    Publication date: March 15, 2012
    Inventors: Andrew R. Blight, Lawrence Maranucci, Ron Cohen
  • Method of using sustained release aminopyridine compositions
    Publication number: 20050228030
    Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at about 12 hours and the use of the composition to treat various neurological diseases, including multiple sclerosis. A method of selecting individuals based on responsiveness to a treatment, including, for example, identifying individuals who responded to treatment with a sustained release fampridine composition.
    Type: Application
    Filed: April 8, 2005
    Publication date: October 13, 2005
    Inventors: Andrew Blight, Lawrence Maranucci, Ron Cohen